Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-03-01
2000-05-09
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3152
Patent
active
060604816
ABSTRACT:
Methods for improving insulin sensitivity in a patient using one or more A.sub.2B adenosine receptor antagonists are disclosed. These methods stimulate insulin dependent glucose uptake in muscle.
REFERENCES:
patent: 5204346 (1993-04-01), Shiokawa et al.
patent: 5208240 (1993-05-01), Peet et al.
patent: 5270311 (1993-12-01), Caulkett et al.
patent: 5300298 (1994-04-01), LaNoue
patent: 5446046 (1995-08-01), Belardinelli et al.
patent: 5547942 (1996-08-01), Rapaport
patent: 5631260 (1997-05-01), Belardinelli et al.
patent: 5668139 (1997-09-01), Belardinelli et al.
Feoktistov and Biaggioni, Adenosine A.sub.28 Receptors, Pharmacological Reviews, 1997, pp. 381-402, vol. 49, No. 4, The American Society for Pharmacology and Experimental Therapeutics, USA.
Xu et al., A.sub.1 adenosine receptor antagonism improves glucose tolerance in Zucker rats, American Journal of Physiology, (1998) pp. E271-E279, vol. 24, American Physiological Society.
Crist George H.
LaNoue Kathryn F.
Linden Joel M.
Monahan Thomas J.
Reamer James H.
The Penn State Research Foundation
LandOfFree
Method for improving insulin sensitivity using an adenosine rece does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for improving insulin sensitivity using an adenosine rece, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for improving insulin sensitivity using an adenosine rece will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1065401